Alleviating 'Lou Gehrig's Disease' by Regulating Protein

Identification of a New Pathological Mechanism Involved in the Early Stage of Lou Gehrig's Disease
Elucidation of Early Onset Mechanisms in Various Degenerative Brain Diseases
and Proposal of a Novel Approach for Therapeutic Development

[Asia Economy Reporter Junho Hwang] A new method to regulate the intracellular movement of proteins that cause degenerative brain diseases such as amyotrophic lateral sclerosis (ALS) and dementia in our brain has been discovered. This research is expected to serve as a foundation for developing treatments suitable for the early stages of degenerative brain diseases.

A joint research team led by Professor Seongbae Lee from the Department of Brain and Cognitive Sciences at Daegu Gyeongbuk Institute of Science and Technology and Professor Daehee Hwang from the Department of Biological Sciences at Seoul National University recently introduced their findings in the international journal eLife on the 6th, revealing a key regulatory mechanism controlling the movement of the TDP-43 protein within nerve cells.

The research team discovered a physiological program that regulates the movement of the TDP-43 protein between the nucleus and cytoplasm in nerve cells. They found that a signaling pathway linked to calcium-calpain-importin is involved, causing the location of TDP-43 to change between the cytoplasm and nucleus. Notably, the team also significantly restored motor function in animal models with ALS by regulating the calcium-calpain-importin signaling pathway. Through this, the team proposed a new therapeutic strategy: "By preemptively controlling the movement of TDP-43 protein in the early stages of the disease, before TDP-43 abnormally aggregates and becomes toxic in the cytoplasm of nerve cells, it may be possible to suppress the pathology of degenerative brain diseases."

Currently, ALS lacks precise elucidation of its pathological mechanisms and development of treatments. When affected by this disease, specific damage to motor neurons occurs, and TDP-43, which is mainly present in the nucleus of motor neurons, moves to and accumulates in the cytoplasm. This phenomenon is also observed in patients with various degenerative brain diseases such as frontotemporal dementia, Alzheimer's disease, Huntington's disease, and Parkinson's disease.

Professor Seongbae Lee stated, "This study identified an intrinsic cellular program that controls the intracellular movement of TDP-43, a representative protein causing degenerative brain diseases," adding, "It is expected that new treatment development based on this strategy will be possible for various degenerative brain diseases involving TDP-43, including ALS."

This content was produced with the assistance of AI translation services.